CureVac N.V. (CVAC)
Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)
4.660
-0.010 (-0.21%)
Inactive · Last trade price on Jan 5, 2026
CureVac Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 416.09 | 481.75 | 402.45 | 495.8 | 811.46 | 1,323 |
Cash & Short-Term Investments | 416.09 | 481.75 | 402.45 | 495.8 | 811.46 | 1,323 |
Cash Growth | -24.47% | 19.70% | -18.83% | -38.90% | -38.65% | 4210.37% |
Accounts Receivable | 19.6 | 14.08 | 14.33 | 6.3 | 18.5 | 1.01 |
Other Receivables | - | 2.76 | 2.76 | 2.71 | - | 0.81 |
Total Trade Receivables | 19.6 | 16.84 | 17.08 | 9 | 18.5 | 1.82 |
Inventory | 0.54 | 0.54 | 24.8 | 23.99 | 56.16 | 14.53 |
Other Current Assets | 436.88 | 27.28 | 34.04 | 55.24 | 53.89 | 50.91 |
Total Current Assets | 873.11 | 526.41 | 478.38 | 584.03 | 940.02 | 1,390 |
Net Property, Plant & Equipment | 235.6 | 244.65 | 278.63 | 241.7 | 200.39 | 100.59 |
Other Intangible Assets | 24.68 | 25.16 | 28.35 | 31.78 | 13.24 | 14.15 |
Other Long-Term Assets | 5.23 | 6.61 | 2.9 | 2.96 | 4.59 | 6.77 |
Total Assets | 1,139 | 802.83 | 788.25 | 860.47 | 1,158 | 1,511 |
Accounts Payable | 8.72 | 17.27 | 48.03 | 73.46 | 127.7 | 21.69 |
Current Portion of Leases | 4.77 | 5.32 | 5.01 | 4.98 | 3.47 | 3.23 |
Unearned Revenue | 0.36 | - | 44.58 | 34.76 | 55.75 | 157.99 |
Other Current Liabilities | 222.33 | 49.76 | 105.77 | 43.02 | 170.81 | 64.72 |
Total Current Liabilities | 236.17 | 72.35 | 203.39 | 156.23 | 357.73 | 247.62 |
Long-Term Debt | - | - | - | - | - | 25.19 |
Long-Term Leases | 30.3 | 33.64 | 36.82 | 37.11 | 25.42 | 26.85 |
Other Long-Term Liabilities | 0.82 | 0.23 | 48.1 | 133.89 | 86.61 | 500.35 |
Total Long-Term Liabilities | 31.22 | 33.87 | 84.92 | 170.99 | 112.03 | 552.39 |
Total Liabilities | 267.39 | 106.22 | 288.31 | 327.22 | 469.77 | 800.01 |
Common Stock | 27.02 | 26.92 | 26.88 | 23.4 | 22.45 | 21.66 |
Treasury Stock | - | - | - | -1.48 | -5.82 | - |
Additional Paid-in Capital | - | - | 2,056 | 1,817 | 1,729 | 1,335 |
Accumulated Other Comprehensive Income | -0.31 | 0.04 | -0.07 | -0.14 | -0.03 | 0.06 |
Retained Earnings | -1,242 | -1,404 | -1,583 | -1,306 | -1,057 | -645.07 |
Shareholders' Equity | 871.23 | 696.61 | 499.94 | 533.25 | 688.48 | 711.35 |
Total Liabilities & Equity | 1,139 | 802.83 | 788.25 | 860.47 | 1,158 | 1,511 |
Total Debt | 35.07 | 38.97 | 41.82 | 42.09 | 28.89 | 55.28 |
Net Cash (Debt) | 381.02 | 442.78 | 360.63 | 453.71 | 782.57 | 1,267 |
Net Cash Growth | -13.95% | 22.78% | -20.52% | -42.02% | -38.25% | - |
Net Cash Per Share | - | 1.97 | 1.63 | 2.40 | 4.21 | 9.59 |
Book Value | 871.23 | 696.61 | 499.94 | 533.25 | 688.48 | 711.35 |
Book Value Per Share | - | 3.09 | 2.26 | 2.82 | 3.70 | 5.38 |
Tangible Book Value | 846.55 | 671.45 | 471.59 | 501.48 | 675.24 | 697.2 |
Tangible Book Value Per Share | - | 2.98 | 2.13 | 2.65 | 3.63 | 5.27 |